The cytotoxic effect of anthrax lethal toxin on human lung cells in vitro and the protective action of bovine antibodies to PA and LF

Journal of Applied Toxicology

Volumn 26, Issue 2, 2006, Pages 162-168

  Paddle, Brian M ^a   Wong, Victor K ^b   Muller, Brian D ^b  

^a DEFENCE SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

^b Anadis Limited   (Australia)

Author keywords

Anthrax; Bovine antibodies; Cytotoxicity; Exotoxins; Human lung epithelial cells; Human lung microvascular endothelial cells; Lethal factor; Lungs; Protective antigen

Indexed keywords

ANTHRAX LETHAL FACTOR; ANTHRAX TOXIN; ANTIBODY; BOVINE ANTIBODY; EXOTOXIN; RECEPTOR; TOXIN PROTECTIVE ANTIGEN; UNCLASSIFIED DRUG;

ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; CELL PROLIFERATION; CELL PROTECTION; CELL SECRETION; CELL VIABILITY; COLOSTRUM; CONTROLLED STUDY; CYTOTOXICITY; EDEMA; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; INHALATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG CAVITY; LYMPHATIC SYSTEM; NONHUMAN; NORMAL HUMAN; PATHOLOGY; PHAGOCYTE; PRIORITY JOURNAL; STOICHIOMETRY; VASCULAR ENDOTHELIUM; VEGETATIVE GROWTH;

ANIMALS; ANTIBODIES; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CATTLE; CELL PROLIFERATION; CELL SURVIVAL; COLOSTRUM; ENDOTHELIAL CELLS; HUMANS; LUNG; MUSCLE, SMOOTH, VASCULAR; NEUTRALIZATION TESTS;

BACILLUS ANTHRACIS; BOVINAE;

EID: 33645276822     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1119     Document Type: Article

References (45)

1. Agrawal A, Lingappa J, Leppla SH, Agrawal S, Jabbar A, Quinn C, Pulendran B. 2003. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424: 329-334.
2. Bonuccelli G, Sotgia F, Frank PG, Williams TM, de Almeida CJ, Tanowitz HB, Scherer PE, Hotchkiss KA, Terman BI, Rollman B, Alileche A, Brojatsch J, Lisanti MP. 2005. Anthrax toxin receptor (ATR/TEM8) is highly expressed in epithelial cells lining the toxin's three sites of entry (lung, skin, and intestine). Am. J. Physiol. Cell. Physiol. 288: C1402-C1410.
3. Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JAT. 2001. Identification of the cellular receptor for anthrax toxin. Nature 414: 225-229.
4. Brittingham KC, Ruthel G, Panchal RG, Fuller CL, Ribot WJ, Hoover TA. Young HA, Anderson AO, Bavari S. 2005. Dendritic cells endocytose Bacillus anthracis spores: Implications for anthrax pathogenesis. J. Immunol. 174: 5545-5552.
5. Cote CK, Rea KM, Norris SL, van Rooijen N, Welkos SL. 2004. The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus arthracis spores. Microb. Pathog. 37: 169-175.
6. Cui X, Moayeri M, Li Y, Li X, Haley M, Fitz Y, Correa-Araujo R, Banks SM, Leppla SH, Eichacker PQ. 2004. Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286: R699-R709.
7. Dixon TC, Fadl AA, Koehler TM, Swanson JA, Hanna PC. 2000. Early Bacillus anthracis-macrophage interactions: intracellular survival and escape. Cell. Microbiol. 2: 453-463.
8. Effros RM. 1997. Permeability of the blood-gas barrier. In The Lung: Scientific Foundations, Crystal RG, West JB, Weibel ER, Barnes PJ (eds), 2nd edn. Lippincott-Raven: New York; 1567-1580.
9. Erwin JL, DaSilva LM, Bavari S, Little SF, Friedlander AM, Chanh TC. 2001. Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infect. Immun. 69: 1175-1177.
10. Fedotova IuM, Ulanova AA. 1970. The specificity of anthrax toxin obtained in vitro (Russian) Zh. Mikrobial. Epidemiol. Immunobiol 47(3): 111-113.
11. Friedlander AM. 1986. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J. Biol. Chem. 261: 7123-7126.
12. Friedlander AM, Bhatnagar R, Leppla SH, Johnson L, Singh Y. 1993. Characterization of macrophage sensitivity and resistance to anthrax lethal toxin. Infect. Immun. 61: 245-252.
13. Fritz DL, Jaax NK, Lawrence WB, Davis KJ, Pitt MLM, Ezzell JW, Friedlander AM. 1995. Pathology of experimental inhalation anthrax in the Rhesus monkey. Lab. Invest. 73: 691-702.
14. Gill JR, Melinek J. 2002. Inhalational anthrax: Gross autopsy findings. Arch. Pathol. Lab. Med. 126: 993-994.
15. Guarner J, Jernigan JA, Shieh WJ, Tatti K, Flannagan LM, Stephens DS, Popovic T, Ashford DA, Perkins BA, Zaki SR, Inhalational Anthrax Pathology Working Group. 2003. Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am. J. Pathol. 163: 701-709.
16. Guidi-Rontani C, Levy M, Ohayon H, Mock M. 2001. Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol. Microbiol. 42: 931-938.
17. Guidi-Rontani C, Weber-Levy M, Labruyère E, Mock M. 1999. Germination of Bacillus anthracis spores within alveolar macrophages. Mol. Microbiol. 31: 9-17.
18. Hanna PC, Acosta D, Collier RJ. 1993. On the role of macrophages in anthrax. Proc. Natl Acad. Sci. USA 90: 10198-10201.
19. Hanna PC, Kochi S, Collier RJ. 1992. Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. Moll. Biol. Cell. 3: 1269-1277.
20. Keppie J, Smith H, Harris-Smith PW. 1955. The chemical basis of the virulence of Bacillus anthracis. III: The role of terminal bacteraemia in death of guinea pigs from anthrax. Br. J. Exp. Pathol. 36: 315-322.
21. Kirby JE. 2004. Anthrax lethal toxin induces human endothelial cell apoptosis. Infect. Immun. 72: 430-439.
22. Kobiler D, Gozes Y, Rosenberg H, Marcus D, Reuveny S, Altboum Z. 2002. Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization. Infect. Immun. 70: 544-550.
23. Lin CG, Kao YT, Liu WT, Huang HH, Chen KC, Wang TM, Lin HC. 1996. Cytotoxic effects of anthrax lethal toxin on macrophage-like cell line J774A.1. Curr. Microbiol. 33: 224-227.
24. Little SF, Ivins BE, Fellows PF, Friedlander AM. 1997. Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs. Infect. Immun. 65: 5171-5175.
25. Little SF, Leppla SH, Friedlander AM. 1990. Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin. Infect. Immun. 58: 1606-1613.
26. Lyons CR, Lovchik J, Hutt J, Lipscomb MF, Wang E, Heninger S, Berliba L, Garrison K. 2004. Murine model of pulmonary anthrax: Kinetics of dissemination, histopathology, and mouse strain susceptibility. Infect. Immun. 72: 4801-4809.
27. Moayeri M, Haines D, Young HA, Leppla SH. 2003. Bacillus anthracis lethal toxin induces TNF-α-independent hypoxia-mediated toxicity in mice. J. Clin. Invest. 112: 670-682.
28. Moayeri M, Martinez NW, Wiggins J, Young HA, Leppla SH. 2004. Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity. Infect. Immun. 72: 4439-447.
29. Mohamed N, Clagett M, Li J, Jones S, Pincus S, D'Alia G, Nardone L. Babin M, Spitalny G, Casey L. 2005. A high-affinity monoclonal antibody to anthrax protective antigen protects rabbits before and after Bacillus anthracis spore challenge. Infect. Immun. 73: 795-802.
30. Paddle BM, Poretski M. 2003. Evaluation of the neutralizing activity of antibodies against ricin in a cytotoxicity assay utilizing human lung epithelial cells. Defence Science and Technology Organization. Australia, Technical Report DSTO-TR-1418.
31. Pandey J, Warburton D. 2004. Knock-on effect of anthrax lethal toxin on macrophages potentiates cytotoxicity to endothelial cells. Microbes Infect. 6: 835-843.
32. Park JM, Greten FR, Li ZW, Karin M. 2002. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297: 2048-2051.
33. Pellizzari R, Guidi-Rontani C, Vitale G, Mock M, Montecucco C. 1999. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFN gamma-induced release of NO and TNF alpha. FEBS Lett. 462: 199-204.
34. Phalen RF, Yeh HC, Prasad SB. 1995. Morphology of the respiratory tract. In Concepts in Inhalation Toxicology, McClellan RO, Henderson RF (eds), 2nd edn. Taylor and Francis: Washington; 129-149.
35. Pickering AK, Osorio M, Lee GM, Grippe VK, Bray M, Merkel TJ. 2004. Cytokine response to infection with Bacillus anthracis spores. Infect. Immun. 72: 6382-6389.
36. Popov SG, Popova TG, Grene E, Klotz F, Cardwell J, Bradburne C, Jama Y, Maland M, Wells J, Nalca A, Voss T, Bailey C, Alibek K. 2004. Systemic cytokine response in murine anthrax. Cell. Microbiol. 6: 225-233.
37. Popov SG, Villasmil R, Bernardi J, Grene E, Cardwell J, Popova T, Wu A, Alibek D, Bailey C, Alibek K. 2002a. Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells. FEBS Lett. 527: 211-215.
38. Popov SG, Villasmil R, Bernardi J, Grene E, Cardwell J, Wu A, Alibek D, Bailey C, Alibek K. 2002b. Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem. Biophys. Res. Commun. 293: 349-355.
39. Ross JM. 1957. Pathogenesis of anthrax following administration of spores by the respiratory route. J. Pathol. Bacteriol. 73: 485-494.
40. Ruthel G, Ribot WJ, Bavari S. Hoover TA. 2004. Time-lapse confocal imaging of developmemt of Bacillus anthracis in macrophages. J. Infect. Dis. 189: 1313-1316.
41. Sawada-Hirai R, Jiang I, Wang F, Sun SM, Nedellec R, Ruther P, Alvarez A, Millis D, Morrow PR, Kang AS. 2004. Human antianthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed. J. Immune Based Ther. Vaccines 2: 5.
42. Scobie HM, Rainey JA, Bradley KA, Young JAT. 2003. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl Acad. Sci. USA 100: 5170-5174.
43. Smith H. 2002. Discovery of the anthrax toxin: the beginning of studies of virulence determinants regulated in vivo. Int. J. Med. Microbiol. 291: 411-417.
44. Warfel JM, Steele AD, D'Agnillo F. 2005. Anthrax lethal toxin induces endothelial barrier dysfunction. Am. J. Pathol. 166: 1871-1881.
45. Weibel ER. 1997. Design and morphometry of the pulmonary gas exchanger. In The Lung: Scientific Foundations, Crystal RG, West JB, Weibel ER, Barnes PJ (eds), 2nd edn. Lippincott-Raven: New York; 1147-1157.